Search results for "Prophylaxis"

showing 10 items of 175 documents

COST-EFFECTIVENESS ANALYSIS OF ANTIBIOTIC USE IN DENTAL IMPLANT THERAPY

2021

antibiotic prophylaxisimplant placement
researchProduct

Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis

2019

anticmirbial prophylaxisimmune thrombocytopeniaanti-CD20 immunesuppressive therapy
researchProduct

Adapting to a Global Health Challenge: Managing Antimicrobial Resistance in the Nordics

2020

This article explores the adaptation of Norway and Sweden to one of the major challenges to global public health, antimicrobial resistance (AMR). Guided by assumptions derived from institutional theory, the article investigates whether, and, if so, how the AMR problem has affected the two Nordic countries’ administrative systems and frameworks for Nordic cooperation. The article builds on selected literature, expert interviews, and public documents. The findings suggest that the international impact on Norway and Sweden’s managerial adaptation to AMR is limited. Instead, adaptation takes place through incremental change within existing structures for disease prevention and control and follo…

disease controlmedicine.medical_specialtyEuropäisierungPublic AdministrationSociology and Political ScienceNordeuropanordic cooperationControl (management)Northern Europecooperation010501 environmental sciences01 natural sciencesVDP::Samfunnsvitenskap: 200::Statsvitenskap og organisasjonsteori: 240Politicslcsh:Political science (General)Antibiotic resistanceKooperationeuropeanizationPolitical science050602 political science & public administrationGlobal healthmedicinenorwayantimicrobial resistancelcsh:JA1-92Institutional theoryAdaptation (computer science)Social sciences sociology anthropologyEuropeanizationNorwegen0105 earth and related environmental sciencesSwedenSozialwissenschaften SoziologiePublic economicsNorwayHealth PolicyswedenPublic healthpublic healthdisease prevention05 social sciencesProphylaxe0506 political sciencePeer reviewantimicrobial resistance; disease control; disease prevention; public administrationddc:300GesundheitspolitikprophylaxisSchweden
researchProduct

Weitere Migräne-Studie der Modellvorhaben veröffentlicht: Effektivität der Akupunktur zur Prophylaxe der Migräne: eine multizentrische, randomisierte…

2006

Background Our aim was to assess the efficacy of a part-standardised verum acupuncture procedure, in accordance with the rules of traditional Chinese medicine, compared with that of part-standardised sham acupuncture and standard migraine prophylaxis with beta blockers, calcium-channel blockers, or antiepileptic drugs in the reduction of migraine days 26 weeks after the start of treatment. Methods This study was a prospective, randomised, multicentre, doubleblind, parallel-group, controlled, clinical trial, undertaken between April 2002 and July 2005. Patients who had two to six migraine attacks per month were randomly assigned verum acupuncture (n = 313), sham acupuncture (n = 339), or sta…

education.field_of_studymedicine.medical_specialtybusiness.industryPopulationTraditional Chinese medicinemedicine.diseaseMigraine prophylaxislaw.inventionClinical trialComplementary and alternative medicineRandomized controlled trialMigrainelawInternal medicineAcupuncturemedicineSham acupunctureNeurology (clinical)educationbusinessDeutsche Zeitschrift für Akupunktur
researchProduct

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial.

2011

Background: Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates. Methods: This is a secondary analysis of data from a multicenter randomized controlled trial where preterm VLBW neonates randomly received bLF (100 mg/day; group A1), bLF + Lactobacillus rhamnosus GG (106 colony-forming units per day; group A2), or placebo (group B) for 6 weeks. Here we analyze the incidence rates of fungal colonization, invasive fungal infection (IFI), and rate of progression from colonization to infection in all groups. Results: This study included 472 neonates who…

fungal sepsisDiseasesInfant Premature DiseasesPediatricsGastroenterologylactoferrin; VLBW neonates; Candida; fungal sepsis; prophylaxisGroup BSettore MED/38 - Pediatria Generale E SpecialisticaAnti-Infective AgentsInfant Very Low Birth WeightCandidabiologyLactoferrinBovine lactoferrin fungal infections very low birth weight newbornsPerinatology and Child Healthlactoferrinprophylaxismedicine.symptomInfant Prematuremedicine.medical_specialtyFungal sepsisPlaceboSepsisLactobacillus rhamnosusIntolerancesInternal medicinemedicineAnimalsHumansfungal sepsiAdverse effectPrematureProphylaxisbusiness.industryVery Low Birth WeightProbioticsInfant NewbornInfantNewbornbiology.organism_classificationmedicine.diseaseLactoferrinLow birth weightMycosesVLBW neonatesPediatrics Perinatology and Child HealthImmunologyCandida; Fungal sepsis; Lactoferrin; Prophylaxis; VLBW neonates; Animals; Anti-Infective Agents; Cattle; Humans; Infant Newborn; Infant Premature; Infant Premature Diseases; Lactoferrin; Mycoses; Probiotics; Infant Very Low Birth Weight; Pediatrics Perinatology and Child Healthbiology.proteinCattlebusiness
researchProduct

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study.

2017

Background: More than 50% of patients with Crohn's disease require intestinal resection at least once. Postoperative recurrence (POR) is almost uniform if prophylactic treatment is not started early. Endoscopic monitoring is generally advised. We studied the incidence and management of recurrence in patients who had undergone intestinal resection. Methods: Practicrohn was an observational retrospective study performed in 26 Spanish hospitals including patients aged >= 18 years who underwent Crohn's disease-related ileocolonic resection between January 2007 and December 2010. We recorded preventive treatments, the incidence of clinical recurrence in daily practice, and associated risk factor…

intestinal resectionAdultMaleReoperationmedicine.medical_specialtymedicine.medical_treatment03 medical and health sciencesYoung Adult0302 clinical medicineCrohn DiseaseInterquartile rangeRecurrenceRisk FactorsSecondary Preventionpostoperative recurrenceImmunology and AllergyMedicineHumansImmunologic FactorsPostoperative PeriodColectomyColectomyRetrospective StudiesCrohn's diseasemedicine.diagnostic_testbusiness.industryIncidence (epidemiology)IncidenceGastroenterologyRetrospective cohort studyEndoscopyBowel resectionmedicine.diseaseSurvival AnalysisEndoscopySurgeryCrohn's diseaseLogistic ModelsSpain030220 oncology & carcinogenesisPopulation study030211 gastroenterology & hepatologyFemaleprophylaxisbusinessFollow-Up StudiesInflammatory bowel diseases
researchProduct

Antifungal prophylaxis of oropharyngeal mucositis with itraconazole during adjuvant chemotherapy in colorectal cancer (CRC)patients.

2008

itraconazole prophylaxis mucositis
researchProduct

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled rando…

2019

Abstract Background Hereditary angioedema (HAE) is a debilitating disorder resulting from C1-esterase inhibitor (C1-INH) deficiency. In the COMPACT phase 3 study the prophylactic use of a subcutaneous C1 inhibitor (C1-INH [SC], HAEGARDA®, CSL Behring) twice weekly significantly reduced the frequency of acute edema attacks. Analysis of treatment effects by subgroups, onset of effect, and other exploratory analysis have not been reported. Methods This is a post hoc exploratory analysis on data from the randomized, placebo-controlled COMPACT study. 90 patients with C1-INH-HAE were randomized to 1 of 4 treatment sequences: C1-INH (SC) 40 or 60 IU/kg of body weight twice weekly for 16 weeks, pre…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyPhases of clinical researchSubgroup analysisReplacement therapyPlacebolaw.invention03 medical and health sciences0302 clinical medicineC1-INH (SC)Randomized controlled trialHAEGARDA®lawInternal medicinePost-hoc analysisMedicine030212 general & internal medicineDosingCOMPACT studyHereditary angioedemabusiness.industryResearchSubcutaneousGeneral Medicinemedicine.diseaseClinical trialLong-term prophylaxis030228 respiratory systemC1-esterase inhibitor proteinHereditary angioedemabusinesslcsh:RC581-607Allergy, Asthma & Clinical Immunology
researchProduct

Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.

2017

Myelodysplastic Syndromes are oligo-clonal stem cell disorders that are associated with cytopenias in the peripheral blood. Major causes for morbidity and mortality in myelodysplastic syndromes (MDS) patients are infections mostly due to bacteria or fungi. Beside leucopenia per se in affected patients, function of white blood cells particularly that of neutrophils seems to be impaired. Here we summarize the available data on infections in MDS patients in general and particularly those treated with 5-azacitidine.

medicine.medical_specialtyAntimetabolites AntineoplasticNeutropeniaAzacitidineInfections03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansIn patientMortalityInfection Controlbusiness.industryMyelodysplastic syndromesHematologyGeneral MedicineAntibiotic Prophylaxismedicine.diseasePeripheral blood030220 oncology & carcinogenesisMyelodysplastic SyndromesAzacitidineStem cellMorbiditybusiness030215 immunologymedicine.drugEuropean journal of haematology
researchProduct

The orthopaedic status of severe haemophiliacs in Spain

2000

Summary. This paper provides an outline of the results obtained in a cross-sectional study conducted primarily with the aim of ascertaining orthopaedic complications in a group of young severe A and B haemophiliacs, the effects which these complications have on the medical resources used with these patients, and the impact of severe haemophilia on their quality of life. Its secondary aim was to link their current orthopaedic status to the type of treatment they had received prior to the study. Eleven Spanish hospitals took part in this study, monitoring 70 severe haemophiliacs (FVIII:C 6 months). In 40 cases (57.1%) the patients underwent one or more periods of prophylaxis. Thirty-three pat…

medicine.medical_specialtyBleeding episodesHaemophilic arthropathyPediatricsbusiness.industrySecondary prophylaxisHematologyGeneral MedicineHaemophiliamedicine.diseasemedicine.anatomical_structureQuality of lifeRadiological weaponOrthopedic surgerymedicineAnklebusinessGenetics (clinical)Haemophilia
researchProduct